33,34 A phase 2 clinical study (NCT04313634) using senolytics (D + Q) to treat bone loss in postmenopausal women showed that patients with higher senescent cell burden had a more significant response to D + Q, manifested as a 34% increase in bone formation and an 11% decrease in bone resorption
Has the BPC-157 and TB-500 combination been studied
This means that though our cells are still making glutathione, the amount is no longer enough to prevent oxidative stress and the cellular damage that ensues
In NOD mice, it delayed T1D onset, reduced insulitis, inhibited the expansion of T-BET+ CTLs, and promoted a T cell exhausted signature in the spleen and pancreatic lymph nodes (122, 123)
Curtis C, Shah SP, Chin S, Turashvili G, Rueda OM, Dunning MJ, et al